Sera Prognostics, Inc.

SERA ·Healthcare, Medical Care Facilities, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Revenue $81.0K $77.0K $306.0K $268.0K $82.0K $25.0K
Cost of Revenue $164.0K $82.0K $210.0K — — —
Gross Profit $-83.0K $-5.0K $96.0K — — —
Gross Margin -102.5% -6.5% 31.4% — — —
Operating Expenses
Research & Development $13.2M $14.7M $15.2M $14.2M $11.0M $7.8M
SG&A Expense $16.7M $16.1M $16.3M $16.8M $14.1M $6.6M
Operating Income $-36.5M $-36.6M $-39.8M $-45.7M $-35.4M $-18.0M
Operating Margin -45,066.7% -47,577.9% -13,013.4% -17,034.3% -43,164.6% -71,884.0%
Interest Expense $9.0K $28.0K $55.0K — — —
Pretax Income $-31.9M $-32.9M — — — —
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income $-31.9M $-32.9M $-36.2M $-44.2M $-35.0M $-19.8M
Net Margin -39,417.3% -42,724.7% -11,843.8% -16,487.3% -42,693.9% -79,392.0%
EPS (Basic) $-0.67 $-0.99 $-1.16 $-1.43 $-1.17 $-0.64
EPS (Diluted) $-0.67 $-0.99 $-1.16 $-1.43 $-1.17 $-0.64
Shares Outstanding (Basic) 47.7M 33.2M 31.2M 30.9M 30.0M 31.1M
Shares Outstanding (Diluted) 47.7M 33.2M 31.2M 30.9M 30.0M 31.1M
Dividends Per Share — — — — — —